Towa Pharmaceutical Co., Ltd. (TYO:4553)

Market Cap	143.74B
Revenue (ttm)	262.18B
Net Income (ttm)	16.00B
Shares Out	49.23M
EPS (ttm)	325.11
PE Ratio	8.98
Forward PE	8.22
Dividend	80.00 (2.69%)
Ex-Dividend Date	Sep 29, 2025

Volume	92,600
Average Volume	141,295
Open	2,968.00
Previous Close	2,920.00
Day's Range	2,942.00 - 3,010.00
52-Week Range	2,298.00 - 3,415.00
Beta	-0.25
RSI	39.83
Earnings Date	Nov 10, 2025

About Towa Pharmaceutical

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 4,788
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4553

Financial Performance

In 2024, Towa Pharmaceutical's revenue was 259.59 billion, an increase of 13.89% compared to the previous year's 227.93 billion. Earnings were 18.99 billion, an increase of 17.39%.